Therapeutic implications from sensitivity analysis of tumor angiogenesis models

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Poleszczuk, Jan ^a,b,c   Hahnfeldt, Philip ^a   Enderling, Heiko ^a,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WARSAW   (Poland)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; BEVACIZUMAB; ENDOSTATIN; FUMAGILLOL CHLOROACETYLCARBAMATE; ANGIOGENESIS INHIBITOR;

ANTIANGIOGENIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; MATHEMATICAL MODEL; PREDICTION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; TUMOR VOLUME; UNCERTAINTY; BIOLOGICAL MODEL; CELL PROLIFERATION; DRUG EFFECTS; ENDOTHELIUM CELL; MOLECULARLY TARGETED THERAPY; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TREATMENT OUTCOME; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; BEVACIZUMAB; CELL PROLIFERATION; ENDOTHELIAL CELLS; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84925651681     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120007     Document Type: Article

References (18)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971; 18: 1182-1184.
2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70. PMID: 10647931
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-674. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
4. Loeb LA. A mutator phenotype in cancer. Cancer Res. 2001; 61: 3230-3239. PMID: 11309271
5. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, et al. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer. 2005; 9: 1599-1610. PMID: 15870830
6. Cooke R. Dr. Folkman's War: Angiogenesis and the Struggle to Defeat Cancer. New York: Random House; 2001.
7. Hahnfeldt P, Panigrahy D, Folkman J, Hlatky L. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. Cancer Res. 1999; 59: 4770-4775. PMID: 10519381
8. Ergun A, Camphausen K, Wein LM. Optimal scheduling of radiotherapy and angiogenic inhibitors. Bull Math Biol. 2003; 65: 407-424. PMID: 12749532
9. D'Onofrio A, Gandolfi A. Tumor eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999). Math Biosci. 2004; 191: 159-184. PMID: 15363652
10. nd ed. New York: Springer; 2011.
11. Ledzewicz U, Schättler H. Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis. J Theor Biol. 2008; 252: 295-312. doi: 10.1016/j.jtbi.2008.02.014 PMID: 18371982
12. Klamka J, wierniak A. Controllability of a model combined anticancer therapy. Control and Cybernetics. 2013; 42: 125-138. doi: 10.1109/TSMCB.2011.2162234 PMID: 21878418
13. Poleszczuk J, Bodnar M, Fory U. New approach to modelling of antiangiogenic treatment on the basis of Hahnfeldt et al. model. Math Biosci Eng. 2011; 8: 591-603. doi: 10.3934/mbe.2011.8.591 PMID: 21631148
14. Fujita K, Sano D, Kimura M, Yamashita Y, Kawakami M, Ishiguro Y, et al. Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma. Oncol Rep. 2007; 18: 47-51. PMID: 17549344
15. Byrd RH, Schnabel RB, Schultz GA. A trust region algorithm for nonlinearly constrained optimization. SIAM J Numer Anal. 1987; 24: 1152-1170.
16. McKay MD, Beckman RJ, Conover WJ. A Comparison of Three Methods for Selecting Values of Input Variables in the Analysis of Output from a Computer Code. Technometrics. 1979; 21: 239-245.
17. Cukier RI, Fortuin CM, Shuler KE, Petschek AG, Schaibly JH. Study of the sensitivity of coupled reaction systems to uncertainties in rate coefficients: i theory. J Chem Phys. 1973; 59: 3873-3878.
18. Saltelli A, Tarantola S, Chan KPS. A quantitative model-independent method for global sensitivity analysis of model output. Technometrics. 1999; 41: 39-56.